BMJ7d
Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis
Department of Neurosurgery, Istituto Nazionale Neurologico C. Besta, Milan, Italy Dr Giovanni Broggi, Department of Neurosurgery, Istituto Nazionale Neurologico C Besta, Via Celoria 11, 20133 Milan, ...
BMJ11d
Calibration of clinical cerebellar and deep brain stimulation systems.
The increasing use of electrical stimulation of the brain for relief of pain, spasticity and epilepsy has introduced unfamiliar techniques into clinical neurological and neurosurgical practice. In ...
BMJ13d
Fasciculation-cramp syndrome preceding anterior horn cell disease: an intermediate syndrome?
1 Department of Neurosciences and Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal 2 Department of Clinical Neuroscience, Barts and the London School of ...
BMJ13d
Ischaemic stroke in anticoagulated patients with atrial fibrillation
Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF). However, recent studies have shown that up to 22%–36% of patients on anticoagulation will suffer an ...
BMJ15d
Benefits and risks of folic acid to the nervous system
Correspondence to: Dr E H Reynolds, Institute of Epileptology, Weston Education Centre, King's College Denmark Hill Campus, Cutcombe Road, London SE5 9PJ, UK During three decades of neurological ...
BMJ15d
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging
Dr R Barber, Institute for the Health of the Elderly, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, U.K. Tel +(0)191 256 3274 ext. 22986; fax +(0)191 219 5048; email ...
BMJ17d
Brain penetration effects of microelectrodes and DBS leads in STN or GPi
Department of Neurology, University of Florida College of Medicine/Shands Hospital, Movement Disorders Center, McKnight Brain Institute, Gainesville, Florida, USA Objective: To determine how ...
BMJ20d
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
Background Incomplete attack remission is the main cause of disability in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Apheresis therapies such as plasma exchange and ...
BMJ20d
Response to: ‘Cortical Inexcitability in ALS: Correlating a Clinical Phenotype’
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ20d
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
Visual hallucinations are common in older people and are especially associated with ophthalmological and neurological disorders, including dementia and Parkinson’s disease. Uncertainties remain ...
BMJ29d
Apomorphine in idiopathic restless legs syndrome: an exploratory study
Correspondence to: Dr Gotthard G Tribl Department of Neurology, University of Vienna, Vienna General Hospital, Waehringer Guertel 18–20, A-1097 Vienna, Austria; gotthard.triblmeduniwien.ac.at ...
BMJ1mon
Insights into Parkinson’s disease from computational models of the basal ganglia
Movement disorders arise from the complex interplay of multiple changes to neural circuits. Successful treatments for these disorders could interact with these complex changes in myriad ways, and as a ...